Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?

Fundamental & Clinical PharmacologyVolume 33, Issue 6 p. 687-688 Editorial Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis? Anastasia Bougea, Anastasia Bougea 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Vassilisis Sophias Avenue 72-74, 11528 Athens, GreeceSearch for more papers by this author Anastasia Bougea, Anastasia Bougea 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Vassilisis Sophias Avenue 72-74, 11528 Athens, GreeceSearch for more papers by this author First published: 16 October 2019 https://doi.org/10.1111/fcp.12513Citations: 1 This editorial refers to the article ‘Is TNF Inhibitor Exposure a Risk Factor for Amyotrophic Lateral Sclerosis?’ by Nadine Petitpain et al. published in Fundamental and Clinical Pharmacology. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume33, Issue6December 2019Pages 687-688 RelatedInformation